Microbix Biosystems Inc T.MBX

Alternate Symbol(s): MBXBF

Healthcare Biotechnology

Microbix Biosystems Inc. develops and commercializes biological and technological solutions for human health and wellbeing. It enables the commercialization of diagnostic assays by making a range of critical ingredients and devices for the global diagnostics industry, notably antigens for immunoassays and its laboratory quality assessment products (QAPs) that support clinical lab proficiency testing, enable assay development and validation, or help ensure the quality of clinical diagnostic workflows. Its segments include development, manufacturing and sales of products relating to the medical diagnostics industry, namely antigens as test ingredients, quality assessment products to help ensure the accuracy of test workflows and viral transport medium to enable collection of patient test samples and, and development and commercialization of novel and proprietary products or technologies, such as Kinlytic. Its Kinlytic urokinase is a biologic thrombolytic drug used to treat blood clots.

TSX:MBX - Post by User

Microbix Biosystems Inc > MBX Microbix on Pharma M&A radar. Buyout MBX $1.25 per share

<< Previous

Bullboard Posts

Next >>

Comment by RazeKreationson May 12, 2022 4:57pm

96 Views

Post# 34679450

RE:MBX Microbix on Pharma M&A radar. Buyout MBX $1.25 per share

That is what i was eluding to when i wrote that it seems that some have an agenda to keep the stock value low to allow someone to pick up mbx cheap. It is a crazy world we live in now without the usual rules and the extremely wealthy taking over everything. 5 record breaking quarters in a row and the stock is down 50%. I probably am crazy but nothing surprises me anymore

<< Previous

Bullboard Posts

Next >>

Changing Europe’s dependency on HREE from China